Evidence map›Paper›PMID 35957608›Full record

ArticleEndocrinology2022

Steroidogenic Factor 1 Regulates Transcription of the Inhibin B Coreceptor in Pituitary Gonadotrope Cells.

Yeu-Farn Lin, Gauthier Schang, Evan R S Buddle, Hailey Schultz, Thea L Willis, Frederique Ruf-Zamojski, Michel Zamojski, Natalia Mendelev, Ulrich Boehm, Stuart C Sealfon and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Intronic Enhancer Is Essential forInternational journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 4 countries.

Yeu-Farn LinDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Quebec H3G 1Y6, Canada.
Gauthier SchangDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Quebec H3G 1Y6, Canada.
Evan R S BuddleDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Quebec H3G 1Y6, Canada.
Hailey SchultzDepartment of Anatomy and Cell Biology, McGill University, Montreal, Quebec H3A 0C7, Canada.
Thea L WillisCentre for Craniofacial and Regenerative Biology, King's College London, London SE1 1UL, UK.
Frederique Ruf-ZamojskiDepartment of Neurology, Center for Advanced Research on Diagnostic Assays, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Michel ZamojskiDepartment of Neurology, Center for Advanced Research on Diagnostic Assays, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Natalia MendelevDepartment of Neurology, Center for Advanced Research on Diagnostic Assays, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Ulrich BoehmDepartment of Experimental Pharmacology, Center for Molecular Signaling, Saarland University School of Medicine, Homburg 66421, Germany.
Stuart C SealfonDepartment of Neurology, Center for Advanced Research on Diagnostic Assays, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Cynthia L AndoniadouCentre for Craniofacial and Regenerative Biology, King's College London, London SE1 1UL, UK.
Daniel J BernardDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Quebec H3G 1Y6, Canada.ORCID 0000-0001-5365-5586
McGill University · CAIcahn School of Medicine at Mount Sinai · USKing's College London · GBSaarland University · DE

Funding

MOLECULAR MECHANISM OF AGONISM AT THE GNRH RECEPTORR01DK046943 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI STUART C. SEALFON · 1993 to 2026
$11.0M
Integrated systems biology of the pituitaryR56DK046943 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SEALFON, STUART C. · 2006 to 2024
$555k
Medical Research Council MR/T012153/1NIDDK NIH HHS R01 DK046943NIDDK NIH HHS R56 DK046943
6 · The paper itself

Abstract

The inhibins control reproduction by suppressing follicle-stimulating hormone synthesis in pituitary gonadotrope cells. The newly discovered inhibin B coreceptor, TGFBR3L, is selectively and highly expressed in gonadotropes in both mice and humans. Here, we describe our initial characterization of mechanisms controlling cell-specific Tgfbr3l/TGFBR3L transcription. We identified two steroidogenic factor 1 (SF-1 or NR5A1) cis-elements in the proximal Tgfbr3l promoter in mice. SF-1 induction of murine Tgfbr3l promoter-reporter activity was inhibited by mutations in one or both sites in heterologous cells. In homologous cells, mutation of these cis-elements or depletion of endogenous SF-1 similarly decreased reporter activity. We observed nearly identical results when using a human TGFBR3L promoter-reporter. The Tgfbr3l gene was tightly compacted and Tgfbr3l mRNA expression was essentially absent in gonadotropes of SF-1 (Nr5a1) conditional knockout mice. During murine embryonic development, Tgfbr3l precedes Nr5a1 expression, though the two transcripts are fully colocalized by embryonic day 18.5 and thereafter. Collectively, these data indicate that SF-1 directly regulates Tgfbr3l/TGFBR3L transcription and is required for postnatal expression of the gene in gonadotropes.

Indexed as

Gene Expression RegulationReceptors, Transforming Growth Factor betaSteroidogenic Factor 1AnimalsFemaleFollicle Stimulating HormoneHomeodomain ProteinsInhibinsMicePregnancyRNA, MessengerFollicle Stimulating HormoneHomeodomain Proteinsinhibin BInhibinsReceptors, Transforming Growth Factor betaRNA, MessengerSteroidogenic Factor 1steroidogenic factor 1, mousecell lineinhibinknockout mousepituitaryreceptortranscription

Identifiers

PMID35957608
PMCPMC9761571
OpenAlexW4291156442

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.